Ying K. Tam
Acuitas Therapeutics (Canada)(CA)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Rational design of cationic lipids for siRNA delivery(2010)1,750 cited
- → The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs(2019)1,495 cited
- → Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**(2012)1,192 cited
- → Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes(2015)999 cited
- → Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination(2017)875 cited
- → In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates(2021)725 cited
- → Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses(2021)677 cited
- → Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA(2012)652 cited
- → Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics(2013)602 cited
- → Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses(2018)506 cited